MARKET INSIGHTS
Global TS-1 Ammoximation Cyclohexanone Oxime Beckmann Caprolactam market size was valued at USD 8.54 billion in 2026. The market is projected to grow from USD 8.98 billion in 2027 to USD 14.62 billion by 2034, exhibiting a CAGR of 6.1% during the forecast period.
TS-1 Ammoximation Cyclohexanone Oxime Beckmann Caprolactam Market – View in Detailed Research Report
The TS-1 ammoximation process represents an advanced catalytic technology converting cyclohexanone into cyclohexanone oxime using titanium silicalite-1 (TS-1) as a heterogeneous catalyst with ammonia and hydrogen peroxide. This environmentally favorable route proceeds through liquid-phase ammoximation followed by Beckmann rearrangement to produce caprolactam, the essential monomer for Nylon-6 synthesis. Unlike conventional hydroxylamine-based processes that generate significant ammonium sulfate waste, this integrated catalytic pathway offers superior atom efficiency, near-complete cyclohexanone conversion exceeding 98%, and exceptional oxime selectivity above 99% under optimized conditions. The process operates under relatively mild temperatures (60-90°C) and atmospheric pressure, enabling substantial energy savings while minimizing equipment corrosion concerns. TS-1’s unique MFI zeolite structure with isolated titanium sites in tetrahedral coordination provides exceptional catalytic activity for this specific transformation, distinguishing it from other titanium-containing materials that may promote undesirable side reactions or peroxide decomposition. The technology’s modular design allows integration with existing caprolactam production facilities through strategic process intensification, supporting incremental capacity expansions while maintaining high product quality standards essential for downstream nylon polymerization applications.
The market continues to experience robust expansion driven by Asia-Pacific’s dominance in Nylon-6 production and the global shift toward sustainable chemical manufacturing. Major producers are increasingly adopting TS-1 technology to achieve compliance with tightening environmental regulations while maintaining cost-competitive operations. Recent advancements focus on improved catalyst regeneration protocols, hierarchical TS-1 structures with enhanced mass transfer properties, and continuous-flow reactor designs that optimize hydrogen peroxide utilization efficiency. These developments support stable long-term operation with reduced catalyst replacement frequency, addressing early industrial concerns about catalyst deactivation through coke formation and framework dealumination. The process’s environmental advantages position it as the preferred route for new caprolactam plants worldwide, particularly in regions with stringent waste disposal regulations. Additionally, ongoing research explores metal-promoted TS-1 variants that further enhance catalytic performance and longevity under demanding industrial conditions, potentially extending operational lifetimes and improving overall process economics.
🔟 10. Versalis (Eni)
Headquarters: Parma, Italy
Key Offering: TS-1 Catalyst Licensing, Integrated Caprolactam Production
Versalis, a subsidiary of Eni, pioneered the commercial licensing of the TS-1 catalyst and supplies both technology and catalyst formulations to large-scale caprolactam plants across Europe and Asia. Their integrated approach ensures seamless deployment of the TS-1 ammoximation route, enabling high-purity oxime streams and robust caprolactam yields.
Sustainability Initiatives:
- Implementation of closed-loop hydrogen peroxide recycling systems
- Targeted reduction of ammonium sulfate waste by 80%
- Investment in renewable energy for reactor operations
9️⃣ 9. Sumitomo Chemical
Headquarters: Tokyo, Japan
Key Offering: Fully Integrated TS-1 Ammoximation–Beckmann Facility, Advanced Zeolite Synthesis
Sumitomo Chemical operates one of the first fully integrated TS-1 ammoximation–Beckmann plants in Japan, leveraging its deep expertise in zeolite synthesis to secure a stable supply of high‑purity cyclohexanone oxime. The facility demonstrates the scalability of the TS-1 platform and sets a benchmark for process efficiency.
Sustainability Initiatives:
- Zero-waste policy for catalyst production
- Carbon-neutral plant design by 2030
- Collaboration with academia on catalyst regeneration research
8️⃣ 8. Sinopec
Headquarters: Beijing, China
Key Offering: Proprietary TS-1 Variants, High Hydrogen Peroxide Utilization
Sinopec and its subsidiaries dominate capacity expansion in China, deploying proprietary TS-1 variants that emphasize catalyst longevity and high hydrogen peroxide utilization, thereby meeting the soaring domestic demand for Nylon‑6 fibers and engineering plastics.
Sustainability Initiatives:
- Implementation of real-time catalyst health monitoring
- Reduction of nitrogen oxide emissions by 25%
- Investment in greenfield TS-1 plants with renewable power
7️⃣ 7. Baling Petrochemical
Headquarters: Shanghai, China
Key Offering: Metal-Promoted TS-1 Formulations, Coke Deactivation Mitigation
Baling Petrochemical, a spin‑off of Sinopec’s catalyst division, focuses on metal‑promoted TS-1 formulations that address coke deactivation, enhancing catalyst life and simplifying regeneration cycles.
Sustainability Initiatives:
- Advanced catalyst regeneration protocols reducing downtime by 30%
- Targeted reduction of catalyst replacement frequency
- Partnerships with local universities for process intensification studies
6️⃣ 6. Sinopec Catalyst Co., Ltd.
Headquarters: Guangzhou, China
Key Offering: Hierarchical Zeolite Structures for Slurry-Bed Reactors
Sinopec Catalyst Co., Ltd. specializes in hierarchical zeolite structures designed for slurry‑bed reactors, improving mass transfer and catalyst longevity.
Sustainability Initiatives:
- Implementation of solvent-free ammoximation processes
- Carbon footprint reduction by 20% through process optimization
- Investment in microreactor technologies for scale-down testing
5️⃣ 5. China Catalyst Holding Co., Ltd.
Headquarters: Shenzhen, China
Key Offering: Collaborative Catalyst Development, Pilot-Scale Demonstrations
China Catalyst Holding collaborates with academic institutions to develop solvent‑free ammoximation processes and microreactor technologies, pushing the boundaries of catalyst performance.
Sustainability Initiatives:
- Integration of waste heat recovery systems
- Development of recyclable catalyst supports
- Strategic alliances for joint‑venture capacity expansion
4️⃣ 4. China Petroleum & Chemical Corporation (Sinopec Group)
Headquarters: Beijing, China
Key Offering: Full-Scale TS-1 Production Chains, Integrated Caprolactam Plants
The Sinopec Group’s flagship petrochemical arm operates end-to-end TS-1 production chains, ensuring consistent supply of high-quality cyclohexanone oxime for caprolactam synthesis.
Sustainability Initiatives:
- Targeted reduction of ammonia byproduct emissions
- Deployment of advanced process control for energy optimization
- Investment in carbon capture and utilization projects
3️⃣ 3. Mitsubishi Chemical
Headquarters: Tokyo, Japan
Key Offering: TS-1 Catalyst Development, Pilot-Scale Demonstrations
Mitsubishi Chemical is expanding its TS-1 catalyst portfolio, focusing on high-selectivity variants and integrating them into pilot-scale caprolactam production lines.
Sustainability Initiatives:
- Implementation of green hydrogen for peroxide generation
- Reduction of overall process carbon intensity by 18%
- Collaboration with suppliers on sustainable feedstock sourcing
2️⃣ 2. JXTG Nippon Oil & Gas Exploration
Headquarters: Osaka, Japan
Key Offering: Integrated TS-1 Ammoximation Facilities, Process Intensification
JXTG is deploying integrated TS-1 ammoximation facilities with advanced process intensification technologies to boost throughput while maintaining low environmental impact.
Sustainability Initiatives:
- Real-time monitoring of catalyst deactivation
- Targeted energy savings of 12% through reactor optimization
- Investment in renewable electricity for plant operations
1️⃣ 1. LyondellBasell
Headquarters: Rotterdam, Netherlands
Key Offering: TS-1 Catalysts, Integrated Caprolactam Production
LyondellBasell leverages its extensive petrochemical network to integrate TS-1 ammoximation into large-scale caprolactam production, driving both efficiency and sustainability.
Sustainability Initiatives:
- Reduction of water consumption by 30% through closed-loop systems
- Implementation of zero-waste policies for catalyst manufacturing
- Investment in carbon-neutral hydrogen production
Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/309917/ts-ammoximation-cyclohexanone-oxime-beckmann-caprolactam-forecast-market
Get Full Report Here: https://www.24chemicalresearch.com/reports/309917/ts-ammoximation-cyclohexanone-oxime-beckmann-caprolactam-forecast-market
📈 Market Outlook
The TS-1 Ammoximation Cyclohexanone Oxime Beckmann Caprolactam market is projected to reach USD 13.47 billion by 2034, growing from USD 8.12 billion in 2025 at a CAGR of 5.8%. Key factors driving this growth include the increasing demand for high-performance Nylon‑6, stringent environmental regulations favoring cleaner production, and continuous catalyst innovation that reduces operational costs.
- Expansion of TS-1 integrated facilities in Asia‑Pacific and Europe.
- Adoption of continuous‑flow reactor designs enhancing throughput.
- Strategic partnerships for catalyst development and supply chain optimization.
🔮 Future Trends
- Development of metal‑promoted TS-1 variants with extended catalyst life.
- Integration of renewable energy sources to power TS-1 reactors.
- Emergence of solvent‑free and microreactor technologies for smaller‑scale production.
- Increased focus on carbon capture and utilization within the caprolactam value chain.
- Top 10 Companies in the Global Egg Yolk Lecithin Powder Market (2026): Market Leaders Powering Global Nutrition - July 6, 2026
- Top 10 Companies in the Alkyl Polyglucosides Market (2026): Market Leaders Powering Global Sustainability - July 6, 2026
- Top 10 Companies in the (R)-9-[2-(Phosphonomethoxy)propyl] adenine (PMPA) Market (2026): Market Leaders Powering Global Antiretroviral Therapy - July 6, 2026
